The inner cell mass (ICM) of mammalian blastocysts consists of pluripotent epiblast and hypoblast lineages, which develop into embryonic and extraembryonic tissues, respectively. We conducted a chemical screen for regulators of epiblast identity in bovine Day 8 blastocysts. From the morula stage onward, in vitro fertilized embryos were cultured in the presence of cellpermeable small molecules targeting nine principal signaling pathway components, including TGFbeta1, BMP, EGF, VEGF, PDGF, FGF, cAMP, PI3K, and JAK signals. Using 1) blastocyst quality (by morphological grading), 2) cell numbers (by differential stain), and 3) epiblast (FGF4, NANOG) and hypoblast (PDGFRa, SOX17) marker gene expression (by quantitative PCR), we identified positive and negative regulators of ICM development and pluripotency. TGFbeta1, BMP, and cAMP and combined VEGF/PDGF/FGF signals did not affect blastocyst development while PI3K was important for ICM growth but did not alter lineage-specific gene expression. Stimulating cAMP specifically increased NANOG expression, while combined VEGF/PDGF/FGF inhibition up-regulated epiblast and hypoblast markers. The strongest effects were observed by suppressing JAK1/2 signaling with AZD1480. This treatment interfered with ICM formation, but trophectoderm cell numbers and markers (CDX2, KTR8) were not altered. JAK inhibition repressed both epiblast and hypoblast transcripts as well as naive pluripotency-related genes (KLF4, TFCP2L1) and the JAK substrate STAT3. We found that tyrosine (Y) 705-phosphorylated STAT3 (pSTAT3 Y705 ) was restricted to ICM nuclei, where it colocalized with SOX2 and NANOG. JAK inhibition abolished this ICM-exclusive pSTAT3 Y705 signal and strongly reduced the number of SOX2-positive nuclei. In conclusion, JAK/STAT3 activation is required for bovine ICM formation and acquisition of naive pluripotency markers. developmental biology, embryo culture, embryonic stem cells, preimplantation embryo, signal transduction
INTRODUCTION
Mammalian blastocysts consist of an outer trophectoderm (TE), which gives rise to extraembryonic tissues, and an inner cell mass (ICM). During development, the ICM segregates into the epiblast and the hypoblast that subsequently develop into the embryo and extraembryonic yolk sac, respectively [1] . In mouse, the two ICM cell types can be distinguished by their gene expression profiles [2] . On the single cell level, epiblast markers, such as fibroblast growth factor (Fgf) 4, Nanog, and Sox2, are inversely correlated with hypoblast markers, such as Fgf receptor (Fgfr) 2 [2] . Several signaling pathways are crucial in balancing nascent epiblast proliferation versus hypoblast differentiation. First, elevated SOX2 (together with POU5F1) up-regulates Fgf4 transcription in a subset of early ICM cells [3] . Locally secreted FGF4 then activates mitogenactivated protein kinase kinase (MAP2K) and phosphatidylinositol 3-kinase (PI3K)-AKT. Both parallel signal streams converge on phosphorylating MAPK, which induces hypoblast lineage commitment in neighboring cells [4] . Increasing or blocking FGF/MAPK signals during early development can convert the entire ICM into hypoblast or epiblast, respectively [5, 6] . Thus, continuous autocrine FGF4-FGFR2 signaling drives stable epiblast-hypoblast segregation and regulates their respective cell numbers. Second, FGF activates Janus kinase/ signal transducer and activator of transcription (JAK/STAT). JAK activation leads to STAT3 phosphorylation and elevated transcription of ground state pluripotency targets, such transcription factors Klf4 [7] and Tfcp2l1 [8, 9] . Both targets are expressed in the mouse ICM [2, 10] , providing an essential connection between extrinsic leukemia inhibitory factor (LIF), which directly activates JAK/STAT, and the naive core pluripotency network. However, LIF also reinforces (PI3K)-AKT-MAPK activation, potentially antagonizing pluripotency [11] . Third, canonical WNT signals stabilize their downstream target b-CATENIN, which enhances pluripotency by relieving the transcriptional repressor TCF3 from Nanog, Tfcp2l, and other pluripotency genes [12] . Pharmacological inhibition of glycogen synthase kinase 3 (GSK3) also prevents b-CATENIN degradation [13] , mimicking endogenous WNT activity, which is detectable in the mouse ICM [14] .
The double inhibition (2i) of MAP2K and GSK3 has led to the development of chemically defined culture conditions that effectively block exit from pluripotency. Embryonic pluripotent stem cells (ePSCs), capable of generating all cell types in an adult animal, can thus be efficiently derived from the epiblast [15, 16] . The 2i medium also promotes in vitro propagation of several murine PSC types [17] [18] [19] and enables the derivation of fully pluripotent (naive) rat ePSCs [20, 21] . Human PSCs cannot be derived or continuously maintained in 2i/LIF alone [22] . However, in the presence of diverse small molecule and cytokine cocktails, 2i/LIF helps to establish human PSCs whose epigenetic, transcriptional, and functional properties resemble a mouse naivelike state [23] [24] [25] [26] [27] [28] [29] [30] .
In bovine, much less is known about signals that regulate epiblast identity and pluripotency. By multiplexed digital mRNA profiling, the expression of ;90% of pluripotency-and lineage-related candidate genes was conserved between mouse and bovine blastocysts [31] . Among the most informative epiblast versus hypoblast transcripts were FGF4 and NANOG versus PDGFRa and SOX17, respectively [31] . On the protein level, NANOG and SOX2 become progressively limited to the ICM and epiblast [32, 33] and mutually exclusive with GATA6 at Day 8 (D8) [32] .
Similar to mouse, FGF/MAPK signaling instructs bovine epiblast cells to begin extraembryonic differentiation. Exogenous FGF4 limits NANOG expression, lifting its inhibition of GATA6 and converting epiblast into hypoblast [32] . Consistent with this, chemical blockade of FGFR phosphorylation and MAPK signaling shifts hypoblast to epiblast gene expression in bovine embryos [34, 35] and respecifies some GATA6-positive hypoblast into NANOG-positive epiblast cells [32] . Increased MAPK inhibitor concentration (2iþ) selectively potentiates an epiblast-specific gene expression signature [31] . This effect is not mediated by MAPK candidates p38, JNK, or ERK5 [31] , suggesting differences in the signaling pathways governing early lineage segregation between mouse and cattle.
Here we conducted a small molecule screen to identify signal pathways that regulate epiblast identity in in vitro fertilized (IVF) bovine blastocysts. Using morphological blastocyst quality, candidate gene expression and immunofluorescence detection as readouts, we identified positive and negative regulators of ICM development and established JAK/ STAT3 as critical signaling components of bovine pluripotency.
MATERIALS AND METHODS
Chemicals were purchased from Sigma-Aldrich, and all embryo manipulations were carried out at 38.58C unless indicated otherwise. All the experiments were direct contemporaneous comparisons, that is, within each IVF run, all the parameters other than the culture condition, that is, dimethyl sulfoxide (DMSO) versus inhibitors, were kept the same.
In Vitro Production of Embryos
In vitro matured oocytes from slaughterhouse ovaries of mixed breed dairy cows were fertilized with frozen-thawed semen from a sire with proven in vitro fertility as described previously [36] . For cumulus-free cultures, the corona was dispersed after IVF for 22-24 h by vortexing oocytes in 500 ll of 1 mg/ml bovine testicular hyaluronidase in Hepes-buffered synthetic oviduct fluid (HSOF) followed by two washes in HSOF. For in vitro culture, 10 embryos were pooled in 20 ll of early SOF medium and cultured for 5 days (D0: fertilization). On D5, embryos were changed into fresh late SOF (LSOF) drops [37] , supplemented with 10 different small molecules that targeted nine principal signal pathway components (Table 1 and Supplemental Fig. S1 ; Supplemental Data are available online at www.biolreprod.org). All the inhibitor stocks were dissolved in DMSO, and solvent controls contained the corresponding amount of DMSO in the culture medium. Tested concentrations were based on published information, usually conducted in cell culture experiments, available from the data sheets. For the broad-spectrum receptor tyrosine kinase inhibitor BI-BF1120, two different concentrations (0.1 and 1.0 lM) were tested. Embryo cultures were overlaid with mineral oil and kept in a humidified modular incubation chamber (ICN Biomedicals Inc.) gassed with 5% CO 2 , 7% O 2 , and 88% N 2 . Embryos were morphologically graded on D7 or D8 as described previously [38] .
Differential Staining
Expanded grade 1 and 2 blastocysts (XB [1] [2] ) were treated with pronase to remove the zona pellucida [39] and exposed to a 1:4 dilution in Hepes-buffered transfer LSOF (THSOF) of rabbit anti-bovine whole serum (B3759; Sigma) for 45 min, rinsed in THSOF with 0.1 mg/ml cold soluble polyvinyl alcohol (PVA, molecular weight: 10 000-30 000) (THSOF-PVA), and placed into a 1:4 dilution in THSOF of guinea pig complement (S1639; Sigma) containing 5 lg/ ml propidium iodide and 40 lg/ml Hoechst 33342 for 15 min. After rinsing in THSOF-PVA, the embryos were mounted (DAKO-mounting medium, S3023; Med-Bio Ltd) on glass slides and examined using an epifluorescence microscope (AX-70; Olympus). Blue and pink colors were designated as ICM and TE cells, respectively [40] , and nuclei numbers were counted the same day using ImageJ (version 1.45s).
RNA Extraction and RT-PCR
Pools of grade 1-2 blastocysts (average of nine embryos per pool) were lysed in 10 ll RNAGEM Tissue PLUS (containing 0.5 ll RNAGEM), and cDNA was synthesized as described previously [31] . Reverse transcriptase was omitted in one sample each time a batch was processed for cDNA synthesis. Primers were designed using NCBI/ Primer-BLAST (Table 2) À1 to 958C while continuously measuring fluorescence); and 4) cooling to 48C. Product identity was confirmed by gel electrophoresis and melting curve analysis. For relative quantification, external standard curves were generated from five serial 10-fold dilutions for each gene in duplicate. One high-efficiency curve (3.6 ! slope ! 3.1, R 2 . 0.99) was saved for each target gene and imported for relative quantification compared to 18S RNA as described previously [41] .
Immunofluorescence
The following antigens were analyzed: SOX2 (AF2018, dilution 1:30; R & D Systems), NANOG (14-5768, dilution 1:100; eBioscience), and pSTAT3 Y705 (9145, dilution 1:100; Cell Signaling). All the protein-free solutions were supplemented with 0.1 mg/ml PVA to prevent embryos sticking to the dish. Blastocysts were fixed in 4% paraformaldehyde for 20 min at room temperature, washed in PBS, transferred into ice-cold absolute methanol for 10 min at À208C, washed again in PBS, and blocked in 5% donkey serum with 0.3% (v/v) Triton X-100 (blocking solution) for at least 90 min. Primary antibodies were incubated overnight at 48C, washed twice in PBS, and incubated with Alexa Fluor 488 or 546 donkey anti-mouse, anti-rabbit, or antigoat secondary immunoglobulin G antibodies (Life Technologies) for 30 min at 38.58C. All the antibodies were diluted in blocking buffer. DNA was counterstained with 5 lg/ml Hoechst 33342 (Sigma). Preparations were washed twice in PBS and once in H 2 O before mounting (DAKO, Med-Bio Ltd.). Negative controls were processed the same way except that the primary MENG ET AL.
antibodies were replaced with blocking buffer. Images were taken on an epifluorescence microscope (BX50; Olympus) and captured with a Spot RT-KE slider camera (Diagnostics Instruments Inc.) using Spot software (version 4.6).
Statistical Analysis
Statistical significance was accepted at P , 0.05 and determined using the two-tailed Fisher exact test for independence in 2 3 2 tables for immunofluorescence data, a generalized linear mixed model with binomial distribution and logit link for developmental data and the residual maximum likelihood method in GenStat (16th edition) for log cell counts and log gene expression data, applying fixed treatment effects and random run and sample within the run effects.
RESULTS

JAK Inhibition Compromises Blastocyst Development
Bovine IVF embryos were cultured in the presence of different small molecules from the morula stage (D5) onward. At least three independent biological replicates were conducted for each drug. Neither blocking TGFb1-, BMP-, EGF-/VEGF-/ PDGF-/FGF-mediated extracellular signals (via SB431542, LDN193189, or AG1478/BI-BF1120, respectively) nor stimulating adenylate cyclase (with Forskolin) affected blastocyst development (Table 3) . Repressing PI3K activity (via AG66 and TGX) decreased grade 1-2 blastocysts (Table 3) . Suppressing JAK/STAT signaling (via JAK2/3 inhibition with AG490 and JAK1/2 inhibition with AZD1480) robustly compromised overall and grade 1-2 blastocyst development relative to DMSO controls (Table 3) . Our qualitative impression of compromised blastocyst development was supported by differential staining (Supplemental Fig. S2 ) and quantification of the number of putative ICM and TE cells. In line with their neutral effect on embryo development, modulators of TGFb1, BMP, combined RTK (VEGFR, PDGFR, FGFR), and cAMP signals did not affect blastocyst nuclei counts (Table 4 ). In accordance with compromising grade 1-2 blastocysts, blocking PI3K or JAK activity significantly decreased ICM numbers. JAK1/2 inhibition was particularly effective, reducing average ICM cell numbers by 
JAK Inhibition Reduces ICM-Specific Gene Expression
In order to correlate changes in morphology and cell numbers with changes in ICM lineage segregation, we next analyzed gene expression changes. We previously identified robust markers for bovine early epiblast (NANOG, FGF4) and hypoblast (PDGFRa, SOX17) cells [31] . Using qPCR, we found that inhibiting TGFb1, BMP, EGF, or PI3K signals did not significantly alter ICM candidate gene expression (Fig. 1) . Stimulating adenylate cyclase increased NANOG levels but did not significantly change FGF4 or hypoblast markers. Across two different concentrations, combined RTK inhibition upregulated FGF4 and, to a lesser extent, NANOG and SOX17, but not PDGFRa. The most robust effect was again observed with JAK inhibitors, in particular on reducing NANOG, which was observed with both AG490 and AZD1480. The latter also strongly reduced FGF4 and hypoblast gene (SOX17, PDGFRa) expression. Because JAK inhibitors had the strongest and most consistent effects in our screen, we focused on them.
JAK Inhibition Reduces Pluripotency-Related but Not TE Genes
In mouse, JAK activation elevates transcription of naive pluripotency factors Klf4 and Tfcp2l1, as well as the Socs3 gene, which is up-regulated by pSTAT3 to form a classic negative feedback loop [42] . By qRT-PCR of whole blastocysts (n ¼ 4 replicates), no reliable correlation was found between JAK2/3 inhibition by AG490 (N ¼ 50 embryos) and transcript levels of either KLF4 and TFCP2L1 or STAT3 and SOCS3 (Fig. 2) . AZD1480 (N ¼ 51 embryos), on the other hand, significantly reduced expression of both pluripotency genes and STAT3 (Fig. 2) . SOCS3 transcription tended to be down-regulated during this treatment (P ¼ 0.13). Neither AG490 nor AZD1480 significantly affected gene expression of TE-specific markers CDX2 and KRT8 (Fig. 2) .
JAK Inhibition Abrogates ICM-Specific STAT3 Phosphorylation
Because AZD1480 was more effective than AG490, we focused on this JAK inhibitor for protein analysis. Pluripotency-related JAK1 signals are known to be specifically mediated through phosphorylation of STAT3 tyrosine (Y) 705 [43] . Using an antibody against pSTAT3 Y705 , we found this modification to be ICM exclusive in D7 (data not shown) and D8 (Fig. 3) blastocysts. Within individual ICM nuclei, pSTAT3 Y705 colocalized with SOX2 and, to a lesser degree, with NANOG staining. After 3 days of DMSO versus AZD1480 exposure, the proportion of pSTAT3 Y705 -and SOX2-stained blastocysts that contained at least one immunoreactive nucleus, was strongly reduced (34/48 ¼ 71% vs. 9/26 ¼ 35%, P , 0.01, and 21/21 ¼ 100% vs. 5/16 ¼ 31%, n ¼ 5, P , 0.001, respectively). In line with the differential staining results, the number of SOX2-positive nuclei in the ICM was also drastically reduced in the presence of AZD1480 (27 6 3 vs. 3 6 2, n ¼ 5, P , 0.001). We conclude that bovine ICM formation and acquisition of pluripotency markers depends on JAK/STAT3 signals.
DISCUSSION
Small Molecule Screen for Regulators of Bovine ICM Development
Using D8 bovine blastocysts as a chemical screening platform, we identified JAK/STAT3 signals as critical for ICM development. Compared to mouse and human, much less is known about the extracellular signals governing bovine pluripotency in situ [44] . We previously titrated inhibition of bovine FGF/MAP2K and WNT signaling to a selective shift of hypoblast-specific gene expression toward epiblast-specific gene expression [31] . This effect was not observed after pharmacologically inhibiting related MAP kinases (p38, JNK, and ERK5), prompting us to investigate other signaling pathways. For this screen, we assessed each pathway individually by applying specific cell-permeable small molecule inhibitors or activators. 
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TGFb
Members of the TGFb superfamily play divergent roles in pluripotency regulation in vitro. TGFb1 stabilizes naive pluripotency in human PSCs [23] . Consequently, TGFb inhibitors are either nonessential for acquiring a naivelike state in human PSCs [25, 27] or induce spontaneous differentiation upon long-term culture of human induced PSCs [30] . By contrast, naive mouse and rat PSCs are destabilized by TGFb1 [45] . Accordingly, inhibitors of TGFb receptor type 1 (TGFbR1) facilitate rat naive PSC derivation [46, 47] . TGFbR1 (ALK-4), the SB431542 target, is present in the bovine ICM [31, 48] . However, neither chemically blocking TGFbRI [32] nor providing exogenous ACTIVIN influences ICM lineage specification in bovine [48] . In contrast to TGFb1, BMP4, an epiblast marker [2] , stabilizes naive mouse ePSCs by inhibiting Mapk [49] and inducing expression of Id genes [50] , both counterbalancing differentiation. The effect of BMPs in human ePSCs is context-dependent and can either stimulate or inhibit NANOG expression [45] . In bovine blastocysts and ICM explants, BMP4, BMPR1A/2, and ID1/2/3, are present [31, 48] . Providing exogenous BMP4 did not affect ICM cultures [48] , whereas supplementing ICM cultures with the BMP4-antagonist NOGGIN up-regulated NANOG levels [48] . However, we did not observe a change in NANOG expression by pharmacologically antagonizing BMP signaling. In summary, signaling mediated by ALK-4/5/7 (driven by TGFb1) and ALK-2/3/6 (driven by BMPs) does not appear to be essential for bovine ICM development and gene expression.
PI3K
Mammalian PI3Ks consist of three classes of lipid kinases that integrate extrinsic signals and translate them into intracellular signals. Class I PI3Ks are further divided into subclasses IA and IB based on their modes of regulation [51] . Class IA PI3Ks form heterodimers of a p110 catalytic subunit, encompassing highly homologous isoforms (p110a, p110b, 110d), and a p85 regulatory subunit. Class IB PI3Ks are heterodimers of a p110c catalytic subunit coupled with regulatory isoforms p101 or p87. Upon stimulation by growth factors or cytokines, class I PI3Ks activate multiple AKT- , FGF4) , hypoblast (PDGFRa, SOX17), trophoblast (CDX2, KRT8), and pluripotency-related (KLF4, TFCP2L1, STAT3, SOCS3) genes. Complementary DNA was extracted from pools of grade 1-2 D8 blastocysts cultured in DMSO versus inhibitor-containing medium. Target gene values were normalized on 18S expression and expressed as fold change (on log 10 axis) over the DMSO control; **P , 0.001 relative to DMSO control.
BOVINE ICM DEVELOPMENT REQUIRES JAK/STAT3 SIGNALS dependent and -independent downstream signaling pathways. PI3K-AKT signals are essential for proliferation of early mouse embryos and ePSCs [11, 52] . Chemically blocking PI3K/AKT signaling reduces proliferation, survival, and Nanog expression [53] , while increased AKT activity promotes cell proliferation, viability, and tumorigenicity [54] [55] [56] . This is mediated by AKT phosphorylation increasing degradation of the cell cycle inhibitor p27
Kip1 [54] and restraining dual leucine zipperbearing kinase, which suppresses self-renewal [57] . At the same time, PI3K-AKT signals activate MAPK, potentially antagonizing pluripotency downstream of FGF4 [4] and LIF [11] . We used three isoform-selective inhibitors to target class I PI3Ks. No effect was observed when using the pan-class I PI3K inhibitor ZSTK alone. However, repressing ubiquitously expressed p110a and p110b activity (via AG66 and TGX or AG66, TGX, and ZSTK) decreased high-quality blastocysts and ICM size. Despite this detrimental effect, no strong lineage-specific changes in gene expression were detected. FGF4 was down-regulated in the combined AG66, TGX, and ZSTK group (P ¼ 0.07), but this was not consistent compared to combined AG66/TGX or ZSTK treatments. This indicates that PI3K I signals are required for ICM cell proliferation and/ or survival but not essential for ICM lineage specification.
Cyclic AMP
Forskolin activates adenylate cyclase and cAMP/PKA signaling, in turn inactivating GSK3 and thus acting synergistically with WNTs [58] . Together with other cytokines, such as members of the TGFb-superfamily (BMP, TGFb-1) and RTKs downstream of FGF2 [26] or PDGF [45] , it is used to culture human embryonic germ cells [59] and helps to establish a mouse naivelike state in human PSCs [24, 25] . In bovine, Forskolin tended to improve maintenance of ICM-derived cultures [60] . This is corroborated by our screen where Forskolin increased NANOG expression 3-fold without significantly altering FGF4 or hypoblast markers. Forskolin inactivates GSK3 in mouse ePSCs [61] . Consequently, it may have selectively up-regulated NANOG through indirectly activating the WNT pathway. Consistent with this mode of action, CHIR99021, another GSK3 inhibitor, also increases NANOG in mouse ePSCs [12] and bovine blastocysts [32, 35] . Forskolin may further mediate its effects through up-regulating gap junction protein connexin 43 expression levels as it does in mouse ePSCs [61] . Gap junction-mediated cAMP signaling has been shown to induce pluripotency gene expression in somatic cells coupled to mouse blastomeres [62] . It would need to be tested if a similar mechanism also operates in bovine blastocysts.
RTK
Downstream of various cytokines and growth factors, RTK signaling plays an important role in regulating naive versus primed pluripotency. Signaling through FGFR, VEGFR, and PDGFR is, collectively, relayed through four parallel pathways: 1) MAPK, 2) PI3K, 3) phospholipase C c (PLCc), and 4) JAK/STAT [4] . All these circuits would be affected by the broad-spectrum RTK inhibitor BI-BF1120. In late mouse blastocysts, pharmacological inhibition of Fgfr/Mapk signals redirects hypoblast cells toward an epiblast fate [5] . A similar, albeit moderate effect was also observed by using variations of the 2i regime on bovine blastocysts [31, 32, 35] and ICMderived cultures [63] . In bovine, FGF-induced MAP2K activity normally limits FGF4 expression in the ICM, leading to strong FGF4 up-regulation upon MAP2K inhibition [31] , which was also observed here. Likewise, blocking bovine MAP2K is tightly correlated with increased NANOG levels [31, 32, 35] , which was again observed in the present study. In contrast to these previous studies, BI-BF1120-increased FGF4 and NANOG mRNA levels did not correlate with decreased hypoblast gene expression. This was unexpected because PDGFRa and SOX17 lie downstream of MAPK in mouse [64] and bovine [31] and should be repressed once NANOGrepression is lifted. Instead, SOX17, but not PDGFRa, was significantly increased. This suggests that at the late bovine blastocyst stage, expression of SOX17 neither solely depends on direct FGF/MAPK activation nor on indirect activation via inhibiting NANOG -mediated repression. BI-BF1120 also blocks VEGF-and PDGF-stimulated signals, which both converge on MAPK. Similar to FGF, blocking autocrine VEGF differentiation signals helps to induce and maintain ground state pluripotency in mouse PSCs [65] . PDGFR, on the other hand, is not expressed in mouse ePSCs, but PDGF supports maintenance and survival of human pluripotency in vitro [45] . To further disentangle the effects of FGF, VEGF, and PDGF signals on bovine pluripotency, more specific gainand loss-of-function approaches would be necessary. As outlined above, MAPK inhibitors phenocopied the effects BI-BF1120 on epiblast gene expression to some degree, whereas PI3K inhibitors did not. While PLCc remains to be tested, the most drastic effects were observed when interfering with the JAK/STAT pathway.
JAK/STAT
In addition to FGF signals, JAK/STAT activation is also triggered by LIF and related members of the interleukin (IL) family. In mouse, LIF and its receptors, LIFR and GP130, are expressed in a reciprocal pattern between TE and ICM, suggesting paracrine secretion from the TE to sustain ICM pluripotency [66] . After the cytokine receptor is engaged, members of the JAK family (JAK1, JAK2, JAK3, and TYK2) are phosphorylated, and in turn, they phosphorylate downstream STAT proteins. Y-Phosphorylation promotes cytosolic STAT dimerization, nuclear translocation, and DNA binding to trigger the transcription of target genes. A number of studies have demonstrated that STAT3 activation is essential for balancing self-renewal of the naive murine pluripotent state against differentiation [43, 67] . Recently, STAT2 has also been identified as an essential initiator of NANOG transcription in mouse ePSCs [68] .
Reports on the functionality of this pathway in bovine are controversial. LIF, LIFR, and GP130 are present in bovine blastocysts [69] . However, supplementing embryo cultures with bovine, human, or mouse LIF has either increased [70, 71] , decreased [72] , or had no effect on TE and ICM cell numbers [73] . Epiblast-specific signaling has not been described in detail, but some signaling components (IL6R, GP130, STAT3, SOCS3) were abundantly detected by digital expression profiling of whole bovine blastocysts [31] . Here, we used two different inhibitors to block JAK signaling. Tyrphostin AG490 and AZD1480 have been widely used as ATP-competitive inhibitors of JAK2/3 and JAK1/2, respectively, which inhibit STAT phosphorylation in vitro and in vivo. Nevertheless, these compounds can produce off-target effects. For example, AZD1480 blocks Aurora A kinase in purified enzyme assays, albeit at significantly higher 50% inhibitory concentrations [74] . It does, however, demonstrate significant JAK2 selectivity over JAK3 and only marginal selectivity over JAK1 at ATP substrate concentrations equaling each enzyme's Michaelis-Menten kinetic constant [74] [75] [76] . At higher concentrations, AG490 also inhibits EGFR phosphorylation and compromises MAPK signals [77] . This can be due to directly preventing JAK1/2 from phosphorylating EGFR when it associates with certain JAK-binding receptors [78] .
Chemically suppressing JAK/STAT signaling, in particular through AZD1480, strongly compromised ICM development without affecting TE cell numbers or marker expression. AG490 only resulted in a moderate and less specific reduction, which may have been due to its potential side effects on EGFR inhibition. Because specifically blocking EGFR (via AG1478) increased ICM cell numbers, these two pathways may have been antagonizing each other. ICM-restricted gene expression of both epiblast and hypoblast markers was much reduced, especially by JAK1/2 inhibition. It remains to be determined if this is due to initial loss of NANOG-dependent epiblast, abrogating paracrine FGF signals, which are required for hypoblast formation.
Among the principal downstream effectors of STAT3 are Klf4 and Tfcp2l1 [79] . The latter is also a WNT/b-CATENIN target, placing it at the intersection of two pathways that confer and sustain naivety in PSCs [8, 9] . JAK1/2, but not JAK 2/3, inhibition significantly reduced expression of both pluripotency genes as well as STAT3.
On the protein level, pSTAT3 Y705 , which is essential for proliferation of naive PSCs [43] , was exclusively detected in ICM nuclei, where it often colocalized with SOX2 and NANOG. The NANOG/SOX2 binding relationship is not fully elucidated, even though SOX2 is the partner most often colocalizing with Nanog [80] . Whilst expression of other pluripotency-related transcription factors, such as POU5F1 and KLF4, extends into the bovine TE [35] , pSTAT3 Y705 , NANOG, and SOX2 were ICM-restricted. JAK1/2 inhibition almost completely extinguished pSTAT3 Y705 signals and also strongly reduced the number of SOX2-positive nuclei in the ICM. NANOG staining tends to be more variable within the ICM. The effect of JAK inhibition on NANOG will be important to quantify in future studies, especially in light of its synergistic interactions with pSTAT3 and repression of SOCS3 [7] .
In conclusion, JAK/STAT3 signals are required for bovine ICM formation and acquisition of pluripotency markers. This suggests that a fundamental molecular aspect of pluripotency regulation is conserved between mouse and cattle. In order to BOVINE ICM DEVELOPMENT REQUIRES JAK/STAT3 SIGNALS capture naive bovine ePSCs, it will be important to determine the ligands and receptors that are physiologically activating this pathway in bovine blastocysts.
